Gaze Contingent Feedback for Anxiety Disorders in Children
Gaze-Contingent Music Reward Treatment for Anxiety Disorders in Children: A Case Series
1 other identifier
interventional
12
1 country
1
Brief Summary
The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of anxiety disorders in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 28, 2017
CompletedFirst Posted
Study publicly available on registry
May 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedSeptember 18, 2018
September 1, 2018
1 year
May 28, 2017
September 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in anxiety symptoms - the Pediatric Anxiety Rating (PARS)
The PARS assesses global anxiety severity across different anxiety disorders in children
Post treatment (1 week after treatment completion)
Secondary Outcomes (1)
Change from baseline in anxiety related emotional disorders symptoms - Child/Parent (the SCARED 41-item)
Post treatment (1 week after treatment completion)
Study Arms (1)
Gaze-contingent feedback
EXPERIMENTALParticipants will receive gaze-contingent feedback according to their viewing patterns
Interventions
Participants will receive gaze-contingent feedback according to their viewing patterns
Eligibility Criteria
You may qualify if:
- Primary diagnosis of GAD, SOP, or SAD.
- Co-morbid attention deficit hyperactivity disorder (ADHD) or depressive disorders must be treated with medication and stable.
- Tics or impulse control problems must be treated with medication, stable and cause minimal or no impairment.
You may not qualify if:
- meet diagnostic criteria for Organic Mental Disorders, Psychotic Disorders, Pervasive Developmental Disorders, or Mental Retardation.
- show high likelihood of hurting themselves or others.
- have not been living with a primary caregiver who is legally able to give consent for the child's participation.
- be a victim of previously undisclosed abuse requiring investigation or ongoing supervision.
- be involved currently in another psycho-social treatment.
- have a serious vision problem that is not corrected with prescription lenses.
- have a physical disability that interferes with their ability to click a mouse button rapidly and repeatedly.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv University
Tel Aviv, 69978, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychology and Neuroscience School of Psychological Sciences Sagol School of Neuroscience Tel Aviv University
Study Record Dates
First Submitted
May 28, 2017
First Posted
May 31, 2017
Study Start
April 1, 2017
Primary Completion
April 1, 2018
Study Completion
April 1, 2018
Last Updated
September 18, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share